TLIK — Arzneiwerk VIDA AG Cashflow Statement
0.000.00%
- €3.00m
- €13.54m
- €59.28m
- 17
- 67
- 11
- 19
Annual cashflow statement for Arzneiwerk VIDA AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | R2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | GAS | GAS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 3.87 | 0.825 | -0.245 | -16.6 | -2.88 |
Depreciation | |||||
Non-Cash Items | -0.22 | -0.194 | 0.061 | 0.635 | 0.329 |
Other Non-Cash Items | |||||
Changes in Working Capital | -4.33 | -1.64 | -0.04 | 0.591 | 1.73 |
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -0.66 | -0.986 | -0.203 | 1.13 | 0.194 |
Capital Expenditures | 0 | -0.013 | -0.043 | -1.01 | -0.219 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | -0.03 | -0.091 | 0.005 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0 | -0.013 | -0.073 | -1.1 | -0.214 |
Financing Cash Flow Items | — | — | -0.022 | -0.284 | -0.556 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.6 | 1.74 | -0.084 | 1.07 | -1.17 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.06 | 0.738 | -0.36 | 1.1 | -1.19 |